US Stock MarketDetailed Quotes

HRTX Heron Therapeutics

Watchlist
  • 2.745
  • +0.005+0.18%
Trading Mar 28 15:12 ET
412.65MMarket Cap-3431P/E (TTM)

About Heron Therapeutics Company

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.

Company Profile

SymbolHRTX
Company NameHeron Therapeutics
Listing Date01/23/2014
Issue Price7.00
Founded1983
CEOMr. Craig A. Collard
MarketNASDAQ
Employees126
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4242 Campus Point Court,Suite 200
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-251-4400

Company Executives

  • Name
  • Position
  • Salary
  • Craig A. Collard
  • Director and Chief Executive Officer
  • --
  • Dr. William P. Forbes
  • Executive Vice President and Chief Development Officer
  • --
  • Ira Duarte
  • Executive Vice President and Chief Financial Officer
  • --
  • Dr. Thomas B. Ottoboni
  • Chief Scientific Officer and Senior Vice President, Pharmaceutical and Translational Sciences
  • --
  • Chris Storgard, M.D.
  • Chief Medical Officer
  • --
  • Lisa Peraza
  • Vice President and Chief Accounting Officer
  • 796.76K
  • Sean T. Ristine
  • Senior Vice President, Human Resources
  • --
  • Dr. John C. Arthur, PhD
  • Vice President, Manufacturing and Supply
  • --
  • Robert Sullivan
  • Senior Vice President, Oncology Care Franchise and Commercial Operations
  • --
  • Laura Singer
  • Vice President, Quality Assurance
  • --
  • Jason Grillot
  • Vice President, Sales and Marketing, Acute Care
  • --
  • Adam Morgan
  • Chairman of the Board
  • --
  • Craig A. Johnson
  • Lead Independent Director
  • 339.23K
  • Christian Waage
  • Independent Director
  • 309.23K
  • Susan Rodriguez
  • Independent Director
  • 288.90K
  • Dr. Sharmila Dissanaike, F.A.C.S.,M.D.
  • Independent Director
  • 285.31K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg